R9-6-362. Meningococcal Invasive Disease

A. Case control measures: 1. A diagnosing health care provider or an administrator of a health care institution, either personally or through a representative, shall isolate and institute droplet precautions for a meningococcal invasive disease case for 24 hours after the initiation of treatment. 2. A local health agency shall: a. Upon receiving a report under R9-6-202 or R9-6- 203 of a meningococcal invasive disease case or suspect case, notify the Department within 24 hours after receiving the report and provide to the Department the information contained in the report; b. Conduct an epidemiologic investigation of each reported meningococcal invasive disease case or suspect case; c. For each meningococcal invasive disease case, submit to the Department, as specified in Table 2.4, the information required under R9-6-206(D); and d. In consultation with the Department, ensure that an isolate or a specimen, as available, from each meningococcal invasive disease case is submitted to the Arizona State Laboratory. B. Contact control measures: A local health agency shall evaluate the level of risk of transmission from each contact’s exposure to a meningococcal invasive disease case and, if indicated, provide or arrange for each contact to receive prophylaxis.